title: A case of diabetic non-ketotic hyperosmolar coma with an increase with plasma 3-hydroxybutyrate.
abstract: We have seen a case of "diabetic non-ketotic hyperosmolar coma" with ketosis. An 84-year-old man was brought into the hospital in a deeply comatous and dehydrated state. The initial blood glucose level was 1252 mg/dl with plasma osmolarity of 435 mOsm/l, but no ketonuria was detected by the nitroprusside method (Ketostix). However, the plasma 3-hydroxybutyrate (3-OHBA) level was 5 mM in a newly developed bedside film test. The serum ketone bodies were later found to be 5.56 and 0.82 mmol/l for 3-OHBA and acetoacetate (AcAc), respectively. A marked increase in glucagon, cortisol and ADH with renal dysfunction (creatinine 5.0 mg/dl) were noted. An abnormal electrocardiogram, occular convergence and chorea like movement disappeared after correction of metabolic disturbances. The moderate level of IRI (14 microU/ml) on admission and a good response to glucagon 2 months after admission also indicate that the present case is a typical hyperosmolar non-ketotic coma. Because of a preferential increase in 3-OHBA, ketonuria seemed to be absent in the regular nitroprusside test. Marked dehydration is thought to cause renal dysfunction, and the increase in ADH may have helped to prevent further aggravation of ketoacidosis. We propose to change the term hyperosmolar non-ketotic coma (HNC) to diabetic hyperosmolar coma (DHC), because sometimes patients with hyperosmolar non-ketotic diabetic coma are ketotic, as seen in the present case. Determination of 3-OHBA or individual ketone bodies in blood is important and essential for the differential diagnosis of diabetic coma. The diagnosis of either ketoacidotic or hyperosmolar coma should be made depending on the major expression of ketoacidosis or hyperglycemic hyperosmolarity.
authors.affiliation: Division of Atherosclerosis, Metabolism and Clinical Nutrition, National Cardiovascular Center, Osaka, Japan.
authors.forename: O
authors.initials: O
authors.lastname: Kinoshita
authors.forename: I
authors.initials: I
authors.lastname: Masuda
authors.forename: M
authors.initials: M
authors.lastname: Suzuki
authors.forename: M
authors.initials: M
authors.lastname: Tsushima
authors.forename: Y
authors.initials: Y
authors.lastname: Nishioeda
authors.forename: T
authors.initials: T
authors.lastname: Matsuyama
authors.forename: H
authors.initials: H
authors.lastname: Kojima
authors.forename: Y
authors.initials: Y
authors.lastname: Harano
mesh_terms: D020155:3-Hydroxybutyric Acid; D058186:Acute Kidney Injury / Q000209:etiology; D000368:Aged; D000369:Aged, 80 and over; D001774:Blood Chemical Analysis; D001786:Blood Glucose / Q000032:analysis; D003681:Dehydration / Q000150:complications / Q000628:therapy; D005440:Fluid Therapy; D006801:Humans; D006885:Hydroxybutyrates / Q000097:blood*; D006944:Hyperglycemic Hyperosmolar Nonketotic Coma / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D007328:Insulin / Q000627:therapeutic use; D007657:Ketone Bodies / Q000097:blood; D008297:Male
chemical_list: D001786:Blood Glucose; D006885:Hydroxybutyrates; D007328:Insulin; D007657:Ketone Bodies; D020155:3-Hydroxybutyric Acid